|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/37664849/ Front Endocrinol (Lausanne). 2023 Aug 18;14:1190473. Abnormal glucose homeostasis and fasting intolerance in patients with congenital porto-systemic shunts Mirjam E van Albada 1, Pratik Shah 2, Terry G J Derks 3, Sabine Fuchs 4, Judith J M Jans 5, Valérie McLin 6, Hubert P J van der Doef 7 Abstract Published on:
Aug-2023
|
https://pubmed.ncbi.nlm.nih.gov/37744533/ NAFLD Review Iran J Public Health. 2023 Aug;52(8):1600-1612. The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis Soheil Hassanipour 1, Ehsan Amini-Salehi 2, Farahnaz Joukar 1 3, Mohammad-Javad Khosousi 1, Farideh Pourtaghi 4, Malek Moein Ansar 5, Marjan Mahdavi-Roshan 6, Forough Heidarzad 1, Golnaz Rashidi-Mojdehi 1, Elham Abdzadeh 1, Azin Vakilpour 7, Fariborz Mansour-Ghanaei 1 3 Abstract Published on:
Sep-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/37702974/ chronic liver disease Review Indian J Pediatr. 2023 Sep 13. An Approach to Investigations of Chronic Liver Disease Aathira Ravindranath 1, Surender Kumar Yachha 2 Abstract Published on:
Sep-2023
|
https://pubmed.ncbi.nlm.nih.gov/37756340/ hepatitis b J Pediatr Gastroenterol Nutr. 2023 Sep 27. Change in Health-related Quality of Life in Youth with Chronic Hepatitis B Living in North America:A 5-year Cohort Study Sarah Jane Schwarzenberg 1, Wendy C King 2, Simon C Ling 3, Karen F Murray 4, Douglas Mogul 5, Philip Rosenthal 6, Norberto Rodriguez-Baez 7, Jeffrey Teckman 8, Kathleen B Schwarz 9; Hepatitis B Research Network (HBRN) Abstract Background: Greater hepatitis-related symptomology is associated with lower health-related quality-of-life (HRQoL) among untreated youth with chronic hepatitis B (CHB). How HRQoL changes over time in this population is unknown. Published on:
Sep-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/37705401/ biliary atresia J Pediatr Gastroenterol Nutr. 2023 Sep 14. Prophylactic Antibiotics to Prevent Cholangitis in Children with Biliary Atresia After Kasai Portoenterostomy: A Meta-Analysis Fatima Safira Alatas 1, Glen Lazarus, Michelle Clarissa Junaidi, Hanifah Oswari Abstract Objectives: A connection between the bowel and bile ducts after the Kasai hepatoportoenterostomy (HPE) procedure poses a risk of ascending cholangitis. There were only a few evidence-based consensuses on the benefits of prophylactic antibiotics. This study aims to assess the value of prophylactic antibiotics in reducing the risk of cholangitis following the Kasai HPE procedure. Published on:
Sep-2023
|
https://pubmed.ncbi.nlm.nih.gov/37762919/ cholestasis J Clin Med. 2023 Sep 15;12(18):5979. Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study Ken Kato 1, Shuichiro Umetsu 2, Takao Togawa 3, Koichi Ito 3, Takayoshi Kawabata 4, Teruko Arinaga-Hino 5, Naoya Tsumura 1, Ryosuke Yasuda 1, Yutaro Mihara 6, Hironori Kusano 6, Shogo Ito 3, Kazuo Imagawa 7, Hisamitsu Hayashi 8, Ayano Inui 2, Yushiro Yamashita 1, Tatsuki Mizuochi 1 Abstract Published on:
Sep-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/37733237/ acute hepatitis Euro Surveill. 2023 Sep;28(38):2300171. Task Force for a rapid response to an outbreak of severe acute hepatitis of unknown aetiology in children in Portugal in 2022 Berta Grau-Pujol 1 2 3, João Vieira Martins 2, Isabel Goncalves 4, Fernanda Rodrigues 5 4, Rita de Sousa 6, Dina Oliveira 7, Joana Bettencourt 8, Diana Mendes 9, Inês Mateus de Cunha 3, Sara Pocinho 10, Ana Firme 3, Benvinda Estela Dos Santos 11, André Peralta Santos 12 2, Maria João Albuquerque 2, Pedro Pinto-Leite 2, Rui Tato Marinho 13 14, Paula Vasconcelos 3 Abstract Published on:
Sep-2023
|
https://pubmed.ncbi.nlm.nih.gov/37769636/ autoimmune hepatitis Swiss Med Wkly. 2023 Aug 31;153:40102. Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study Published on:
Sep-2023
|
|
https://pubmed.ncbi.nlm.nih.gov/37735963/ hepatitis c Liver Int. 2023 Sep 21. Health-related quality of life in patients aged 6-18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir Maria Pokorska-Śpiewak 1 2, Ewa Talarek 1 2, Małgorzata Aniszewska 1 2, Magdalena Pluta 1 2, Anna Dobrzeniecka 2, Magdalena Marczyńska 1 2, Giuseppe Indolfi 3 4 Abstract Background & aims: The aim of this study was to assess the effect of treatment with sofosbuvir/velpatasvir (SOF/VEL) on the health-related quality of life (HRQL) of children with chronic hepatitis C. Published on:
Sep-2023
|
https://pubmed.ncbi.nlm.nih.gov/37770847/ liver injury BMC Pediatr. 2023 Sep 28;23(1):492. Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system Yan Liu # 1 2 3 4 5, Hailong Li # 1 2 3 4, Liang Huang 1 2 3 4, Chaomin Wan 4 6, Huiqing Wang 4 6, Xuefeng Jiao 1 2 3 4, Linan Zeng 1 2 3 4, Zhijun Jia 1 2 3 4 5, Guo Cheng 4 6 7, Lei Zhang 8, Wei Zhang 9 10, Lingli Zhang 11 12 13 14 Abstract Background: Evidence of drug-induced liver injury is abundant in adults but is lacking in children. Our aim was to identify suspected drug signals associated with pediatric liver injury. Published on:
Sep-2023
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
